These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15033511)

  • 1. Determination of accurate KI values for tight-binding enzyme inhibitors: an in silico study of experimental error and assay design.
    Murphy DJ
    Anal Biochem; 2004 Apr; 327(1):61-7. PubMed ID: 15033511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of Ki in a competitive enzyme-inhibition model: comparisons among three methods of data analysis.
    Kakkar T; Boxenbaum H; Mayersohn M
    Drug Metab Dispos; 1999 Jun; 27(6):756-62. PubMed ID: 10348808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theoretical assessment of a new experimental protocol for determining kinetic values describing mechanism (time)-based enzyme inhibition.
    Yang J; Jamei M; Yeo KR; Tucker GT; Rostami-Hodjegan A
    Eur J Pharm Sci; 2007 Jul; 31(3-4):232-41. PubMed ID: 17512176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of experimental design on assessing mechanism-based inactivation of CYP2D6 by MDMA (Ecstasy).
    Van LM; Heydari A; Yang J; Hargreaves J; Rowland-Yeo K; Lennard MS; Tucker GT; Rostami-Hodjegan A
    J Psychopharmacol; 2006 Nov; 20(6):834-41. PubMed ID: 16478752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal design for the dose-response screening of tight-binding enzyme inhibitors.
    Kuzmič P
    Anal Biochem; 2011 Dec; 419(2):117-22. PubMed ID: 21871865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput screening of enzyme inhibition using an inhibitor gradient generated in a microchannel.
    Garcia E; Hasenbank MS; Finlayson B; Yager P
    Lab Chip; 2007 Feb; 7(2):249-55. PubMed ID: 17268628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods for studying reaction kinetics in gas chromatography, exemplified by using the 1-chloro-2,2-dimethylaziridine interconversion reaction.
    Krupcík J; Mydlová J; Májek P; Simon P; Armstrong DW
    J Chromatogr A; 2008 Apr; 1186(1-2):144-60. PubMed ID: 18243224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative structure-activity relationships for the pre-steady state acetylcholinesterase inhibition by carbamates.
    Lin G; Liao WC; Chan CH; Wu YH; Tsai HJ; Hsieh CW
    J Biochem Mol Toxicol; 2004; 18(6):353-60. PubMed ID: 15674842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of picomolar slow tight-binding inhibitors of alpha-fucosidase.
    Chang CF; Ho CW; Wu CY; Chao TA; Wong CH; Lin CH
    Chem Biol; 2004 Sep; 11(9):1301-6. PubMed ID: 15380190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirements for reliable determination of binding affinity constants by saturation analysis approach.
    Borgna JL
    J Steroid Biochem Mol Biol; 2004 Dec; 92(5):419-33. PubMed ID: 15698547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput screening of enzyme inhibitors: automatic determination of tight-binding inhibition constants.
    Kuzmic P; Sideris S; Cregar LM; Elrod KC; Rice KD; Janc JW
    Anal Biochem; 2000 May; 281(1):62-7. PubMed ID: 10847611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple method for determining kinetic constants of slow, tight-binding inhibition.
    Wang ZX
    Anal Biochem; 1993 Sep; 213(2):370-7. PubMed ID: 8238913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative structure-activity relationships for the pre-steady state of Pseudomonas species lipase inhibitions by p-nirophenyl-N-substituted carbamates.
    Lin G; Liao WC; Ku ZH
    Protein J; 2005 May; 24(4):201-7. PubMed ID: 16283542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of competitive enzyme inhibition with end point progress curve data.
    Gutiérrez OA; Danielson UH
    Anal Biochem; 2006 Nov; 358(1):11-9. PubMed ID: 16978578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization.
    Nikolovska-Coleska Z; Wang R; Fang X; Pan H; Tomita Y; Li P; Roller PP; Krajewski K; Saito NG; Stuckey JA; Wang S
    Anal Biochem; 2004 Sep; 332(2):261-73. PubMed ID: 15325294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing the peripheral anionic site of acetylcholinesterase with quantitative structure activity relationships for inhibition by biphenyl-4-acyoxylate-4'-N-Butylcarbamates.
    Lin G; Chen GH; Yeh SC; Lu CP
    J Biochem Mol Toxicol; 2005; 19(4):234-43. PubMed ID: 16173062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput screening of enzyme inhibitors: simultaneous determination of tight-binding inhibition constants and enzyme concentration.
    Kuzmic P; Elrod KC; Cregar LM; Sideris S; Rai R; Janc JW
    Anal Biochem; 2000 Nov; 286(1):45-50. PubMed ID: 11038272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycogen phosphorylase inhibitors: a free energy perturbation analysis of glucopyranose spirohydantoin analogues.
    Archontis G; Watson KA; Xie Q; Andreou G; Chrysina ED; Zographos SE; Oikonomakos NG; Karplus M
    Proteins; 2005 Dec; 61(4):984-98. PubMed ID: 16245298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the binding of inhibitors derived from tetrabromobenzimidazole to the CK2 protein using a QM/MM-PB/SA approach.
    Retegan M; Milet A; Jamet H
    J Chem Inf Model; 2009 Apr; 49(4):963-71. PubMed ID: 19354274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic values for mechanism-based enzyme inhibition: assessing the bias introduced by the conventional experimental protocol.
    Yang J; Jamei M; Yeo KR; Tucker GT; Rostami-Hodjegan A
    Eur J Pharm Sci; 2005 Nov; 26(3-4):334-40. PubMed ID: 16137870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.